Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Intraveno(IV) Iron Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Intraveno(IV) Iron Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Intraveno(IV) Iron Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Fresenius Medical Care
Sanofi
Galenica
Actavis
Pharmacosmos
Allergan
Vifor Pharma
AMAG Pharmaceuticals
Luitpold Pharmaceuticals
American Regent
By Type:
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
By End-User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Intraveno(IV) Iron Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Low Molecular Weight Iron Dextran from 2016 to 2027
-
1.3.2 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Gluconate from 2016 to 2027
-
1.3.3 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Iron Sucrose from 2016 to 2027
-
1.3.4 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Carboxyl Maltose from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.4.3 China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Intraveno(IV) Iron Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Intraveno(IV) Iron Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Low Molecular Weight Iron Dextran
-
3.4.2 Market Size and Growth Rate of Ferric Gluconate
-
3.4.3 Market Size and Growth Rate of Iron Sucrose
-
3.4.4 Market Size and Growth Rate of Ferric Carboxyl Maltose
4 Segmentation of Intraveno(IV) Iron Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Intraveno(IV) Iron Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Hospitals
-
4.4.2 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Ambulatory Surgical Centers
-
4.4.3 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Diagnostic Centers
5 Market Analysis by Regions
-
5.1 China Intraveno(IV) Iron Drugs Production Analysis by Regions
-
5.2 China Intraveno(IV) Iron Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Intraveno(IV) Iron Drugs Landscape Analysis
-
6.1 North China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
6.2 North China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
7 Central China Intraveno(IV) Iron Drugs Landscape Analysis
-
7.1 Central China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
7.2 Central China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
8 South China Intraveno(IV) Iron Drugs Landscape Analysis
-
8.1 South China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
8.2 South China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
9 East China Intraveno(IV) Iron Drugs Landscape Analysis
-
9.1 East China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
9.2 East China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
10 Northeast China Intraveno(IV) Iron Drugs Landscape Analysis
-
10.1 Northeast China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
11 Southwest China Intraveno(IV) Iron Drugs Landscape Analysis
-
11.1 Southwest China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
12 Northwest China Intraveno(IV) Iron Drugs Landscape Analysis
-
12.1 Northwest China Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Fresenius Medical Care
-
13.1.1 Fresenius Medical Care Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Sanofi
-
13.2.1 Sanofi Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Galenica
-
13.3.1 Galenica Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Actavis
-
13.4.1 Actavis Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Pharmacosmos
-
13.5.1 Pharmacosmos Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Allergan
-
13.6.1 Allergan Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Vifor Pharma
-
13.7.1 Vifor Pharma Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 AMAG Pharmaceuticals
-
13.8.1 AMAG Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Luitpold Pharmaceuticals
-
13.9.1 Luitpold Pharmaceuticals Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 American Regent
-
13.10.1 American Regent Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Low Molecular Weight Iron Dextran from 2016 to 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Gluconate from 2016 to 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Iron Sucrose from 2016 to 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Carboxyl Maltose from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure China Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Intraveno(IV) Iron Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Intraveno(IV) Iron Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Intraveno(IV) Iron Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Intraveno(IV) Iron Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Low Molecular Weight Iron Dextran
-
Figure Market Size and Growth Rate of Ferric Gluconate
-
Figure Market Size and Growth Rate of Iron Sucrose
-
Figure Market Size and Growth Rate of Ferric Carboxyl Maltose
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Intraveno(IV) Iron Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Intraveno(IV) Iron Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Figure Market Size and Growth Rate of Diagnostic Centers
-
Table China Intraveno(IV) Iron Drugs Production by Regions
-
Table China Intraveno(IV) Iron Drugs Production Share by Regions
-
Figure China Intraveno(IV) Iron Drugs Production Share by Regions in 2016
-
Figure China Intraveno(IV) Iron Drugs Production Share by Regions in 2021
-
Figure China Intraveno(IV) Iron Drugs Production Share by Regions in 2027
-
Table China Intraveno(IV) Iron Drugs Consumption by Regions
-
Table China Intraveno(IV) Iron Drugs Consumption Share by Regions
-
Figure China Intraveno(IV) Iron Drugs Consumption Share by Regions in 2016
-
Figure China Intraveno(IV) Iron Drugs Consumption Share by Regions in 2021
-
Figure China Intraveno(IV) Iron Drugs Consumption Share by Regions in 2027
-
Table North China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table North China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table North China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure North China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Central China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Central China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Central China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Central China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table South China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table South China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table South China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure South China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table East China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table East China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table East China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure East China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Northeast China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Southwest China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Northwest China Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Fresenius Medical Care
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Medical Care
-
Figure Sales and Growth Rate Analysis of Fresenius Medical Care
-
Figure Revenue and Market Share Analysis of Fresenius Medical Care
-
Table Product and Service Introduction of Fresenius Medical Care
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Galenica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galenica
-
Figure Sales and Growth Rate Analysis of Galenica
-
Figure Revenue and Market Share Analysis of Galenica
-
Table Product and Service Introduction of Galenica
-
Table Company Profile and Development Status of Actavis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis
-
Figure Sales and Growth Rate Analysis of Actavis
-
Figure Revenue and Market Share Analysis of Actavis
-
Table Product and Service Introduction of Actavis
-
Table Company Profile and Development Status of Pharmacosmos
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmacosmos
-
Figure Sales and Growth Rate Analysis of Pharmacosmos
-
Figure Revenue and Market Share Analysis of Pharmacosmos
-
Table Product and Service Introduction of Pharmacosmos
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Vifor Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vifor Pharma
-
Figure Sales and Growth Rate Analysis of Vifor Pharma
-
Figure Revenue and Market Share Analysis of Vifor Pharma
-
Table Product and Service Introduction of Vifor Pharma
-
Table Company Profile and Development Status of AMAG Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMAG Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of AMAG Pharmaceuticals
-
Figure Revenue and Market Share Analysis of AMAG Pharmaceuticals
-
Table Product and Service Introduction of AMAG Pharmaceuticals
-
Table Company Profile and Development Status of Luitpold Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luitpold Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Luitpold Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Luitpold Pharmaceuticals
-
Table Product and Service Introduction of Luitpold Pharmaceuticals
-
Table Company Profile and Development Status of American Regent
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of American Regent
-
Figure Sales and Growth Rate Analysis of American Regent
-
Figure Revenue and Market Share Analysis of American Regent
-
Table Product and Service Introduction of American Regent
-
